名稱 | NACC2-NTRK2/BaF3 |
型號 | CBP73247 |
報價 | ![]() |
特點 | NACC2-NTRK2/BaF3,母細胞:BaF3,凍存條件:90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- 拯救偏頭痛!CGRP及其受體拮抗劑研究進展
- ATCC細胞株的特殊性質(zhì)或標(biāo)志必須在整個培養(yǎng)期間始終存在
- 【連載-企業(yè)參考品】 前列腺癌的診斷參考品的選擇
- KIR3DL3/HHLA2細胞篩選模型
- 重磅!科學(xué)家成功利用免疫細胞運輸抗癌藥物至腫瘤靶點
- CYP1A1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- ANG TIE2:重塑千億血管靶向治療市場,“血管-免疫”協(xié)同治療革命
- 黃金賽道——CDH17靶點
- 免疫治療的下一個靶標(biāo):腫瘤相關(guān)巨噬細胞?
- IHC第三方質(zhì)控品——病理質(zhì)控基石,精準(zhǔn)診斷起點
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細胞株 > kinase激酶細胞株 > CBP73247NACC2-NTRK2/BaF3

- 詳細內(nèi)容
CBP73247 | |
I. Introduction | |
Cell Line Name: | NACC2-NTRK2/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS+2ug/ml puromucin |
Mycoplasma Status: | Negative |
II.Background | |
NACC2, NACC family member 2, is the nucleus accumbens-associated protein 2 that functions as a transcriptional repressor and regulates Tp53, through Mdm2, to decrease cell proliferation (PMID: 22926524). An NACC2 fusion with NTRK2 has been observed in pilocytic astrocytoma (PMID: 23817572). | |
III. Representative Data | |
1.NACC2-NTRK2/BaF3 | |
2. Anti-proliferation assay | |
Figure . Anti-proliferation assay of three reference compounds on the NACC2-NTRK2/BaF3 Stable Cell Line. |